✦ LIBER ✦

Efficacy and safety of interferon and ribavirin therapy in HIV-HCV coinfected patients

✍ Scribed by H. Zylberberg; Y. Benhamou; M.L. Chaix; H. Fontaine; C. Rouzioux; C. Katlama; T. Poynard; C. Bréchot; S. Pol

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Severe transaminitis after interferon–ri

✍ F. Bani-Sadr; E. Krastinova; D. Fromentin; L. Piroth; E. Rosenthal; Y. Quertainm 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 54 KB

Efficacy of safety of therapy with inter

✍ J.A. Galeras; C. Tural; L. Force; S. Montoliu; J.A. Rodriguez de Castro; S. Coll 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 165 KB

HCV E2 genomic variability in HCV-HIV-co

✍ D. Neau; E. Legrand; P. Trimoulet; A.C. Jouvencel; M. Dupon; J.M. Ragnaud; M.E. 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 135 KB

HCV Treatment with Pegylated Interferon

✍ Denholm, J.T.; Wright, E.J.; Street, A.; Sasadeusz, J.J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 51 KB

558 Risk factors for bacterial infection

✍ F. Bani-Sadr; F. Carrat; I. Goderel; H. Driiss; S. Pol; P. Cacoub; C. Perronne 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 237 KB

P1216 EFFICACY AND SAFETY OF SIMEPREVIR

✍ Nakajima, T.; Kimura, M.; Arakawa, T.; Kuwata, Y.; Ozeki, I.; Sato, T.; Ohmura, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 59 KB